Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dosing ethambutol in obese patients.

× No keyword cloud information.

12 in total

1. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity.

Authors: M J Rybak; B J Abate; S L Kang; M J Ruffing; S A Lerner; G L Drusano
Journal: Antimicrob Agents Chemother Date: 1999-07 Impact factor: 5.191

2. High dose ethambutol; an oral alternate for intermittent chemotherapy.

Authors: J A Sbarbaro; L D Hudson
Journal: Am Rev Respir Dis Date: 1974-07

3. Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease.

Authors: David E Griffith; Barbara A Brown-Elliott; Sara Shepherd; Jerry McLarty; Lee Griffith; Richard J Wallace
Journal: Am J Respir Crit Care Med Date: 2005-04-28 Impact factor: 21.405

4. Ethambutol optimal clinical dose and susceptibility breakpoint identification by use of a novel pharmacokinetic-pharmacodynamic model of disseminated intracellular Mycobacterium avium.

Authors: Devyani Deshpande; Shashikant Srivastava; Claudia Meek; Richard Leff; Tawanda Gumbo
Journal: Antimicrob Agents Chemother Date: 2010-03-15 Impact factor: 5.191

Dosing ethambutol in obese patients.

1. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity.

2. High dose ethambutol; an oral alternate for intermittent chemotherapy.

3. Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease.

4. Ethambutol optimal clinical dose and susceptibility breakpoint identification by use of a novel pharmacokinetic-pharmacodynamic model of disseminated intracellular Mycobacterium avium.

5. Pharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection.

Review 6. Antimicrobial dosing in obese patients.

7. Once-daily dosing in dogs optimizes daptomycin safety.

Review 8. What is the best size descriptor to use for pharmacokinetic studies in the obese?

9. High-dose ethambutol: its role in intermittent chemotherapy. A six-year study.

10. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients.

1. Ethambutol pharmacokinetic variability is linked to body mass in overweight, obese, and extremely obese people.